Ravi Viswanathan, 10% Owner at Mersana Therapeutics, Inc. (MRSN), bought 8,140,138 shares at $15.00 ($15.0M) on 2017-07-03, disclosed to the SEC on 2017-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,140,138 | $0 | 0.0% |
| 2 | $15.00 | 1,000,000 | $15.0M | 100.0% |
| Total | $1.84 avg | 8,140,138 | $15.0M | 100% |
| Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |